|
TADA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14710488172432E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33080000019881E-07 |
| Normal-vs-Stage2 |
8.724100E-03 |
| Normal-vs-Stage3 |
2.27300400723607E-11 |
| Normal-vs-Stage4 |
1.30739863379858E-11 |
| Stage1-vs-Stage2 |
5.448600E-01 |
| Stage1-vs-Stage3 |
2.376900E-03 |
| Stage1-vs-Stage4 |
3.978900E-03 |
| Stage2-vs-Stage3 |
1.598380E-02 |
| Stage2-vs-Stage4 |
1.656280E-02 |
| Stage3-vs-Stage4 |
9.545400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.18669560026319E-11 |
| Normal-vs-AfricanAmerican |
8.84079998098031E-09 |
| Normal-vs-Asian |
4.660200E-01 |
| Caucasian-vs-AfricanAmerican |
3.457800E-01 |
| Caucasian-vs-Asian |
3.403000E-01 |
| AfricanAmerican-vs-Asian |
1.450190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.42610367959151E-11 |
| Normal-vs-Female |
1.58910000047641E-07 |
| Male-vs-Female |
1.680620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.047800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.1092000085664E-09 |
| Normal-vs-Age(61-80Yrs) |
2.60919952310701E-10 |
| Normal-vs-Age(81-100Yrs) |
2.936000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.665200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.558800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.714600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.316800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.252000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.232600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.470500E-02 |
| Normal-vs-Grade 2 |
3.81979999997117E-06 |
| Normal-vs-Grade 3 |
1.61169966261809E-10 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
5.849800E-01 |
| Grade 1-vs-Grade 3 |
1.570370E-01 |
| Grade 1-vs-Grade 4 |
2.599100E-04 |
| Grade 2-vs-Grade 3 |
2.388500E-02 |
| Grade 2-vs-Grade 4 |
2.39569997173561E-09 |
| Grade 3-vs-Grade 4 |
3.54740000000353E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.876150E-02 |
| Normal-vs-ccB subtype |
1.62525548574877E-12 |
| ccA subtype-vs-ccB subtype |
8.9855900498037E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10960005020411E-09 |
| Normal-vs-N1 |
3.358300E-02 |
| N0-vs-N1 |
7.959200E-01 |
|
|
